Dilpacimab ELISA Kit
Product Sizes
96 tests
£1373.00
KDJ65301-96TESTS
About this Product
- SKU:
- KDJ65301
- Additional Names:
- ABT-165, PR-1283233, CAS: 1791420-09-1
- Application:
- ELISA
- Extra Details:
- Dilpacimab (formerly ABT-165), a novel dual-variable domain immunoglobulin, targets both delta-like ligand 4 (DLL4) and VEGF pathways. Here, we present safety, pharmacokinetic (PK), pharmacodynamic (PD), and preliminary efficacy data from a phase I study (trial registration ID: NCT01946074) of dilpacimab in patients with advanced solid tumors. Eligible patients (≥18 years) received dilpacimab intravenously on days 1 and 15 in 28-day cycles at escalating dose levels (range, 1.25-7.5 mg/kg) until progressive disease or unacceptable toxicity.
- Format:
- Colorimetric
- Immunogen:
- Dilpacimab
- Physical State:
- Plasma, Serum
- Range:
- 0.31-5 ug/mL
- Sensitivity:
- 0.156 ug/ml
- Shipping Conditions:
- Blue Ice
- Supplier:
- AntibodySystem
- Type:
- Assay Kits: ELISAs
